Inventor · disambiguated record
Tetsuya Kobayashi
Also filed as: KOBAYASHI TETSUYA
34 granted patents·14 pending applications·202 citations·filing 1998–2024
97Inventor score
Top patents by PatentIndex Score
48 records- 0197US10988451B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Apr 27, 2021·10 cites·21 claims
- 0296US11643400B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2021·Granted May 9, 2023·4 cites·20 claims
- 0396US10703733B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jul 7, 2020·12 cites·27 claims
- 0495US11420974B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2020·Granted Aug 23, 2022·4 cites·33 claims
- 0594US9371329B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2014·Granted Jun 21, 2016·26 cites·2 claims
- 0694US8952034B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2010·Granted Feb 10, 2015·29 cites·18 claims
- 0793US10836769B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2019·Granted Nov 17, 2020·6 cites·53 claims
- 0893US10328053B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2017·Granted Jun 25, 2019·4 cites·7 claims
- 0992US11667652B2MCL1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Jun 6, 2023·2 cites·15 claims
- 1092US9296782B2Inhibitors of hepatitis C virusGILEAD SCIENCES INC·Filed 2013·Granted Mar 29, 2016·13 cites·16 claims
- 1190US12054490B2Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2023·Granted Aug 6, 2024·1 cites·20 claims
- 1289US11845723B2Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2020·Granted Dec 19, 2023·3 cites·41 claims
- 1389US9458145B2Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Oct 4, 2016·12 cites·9 claims
- 1489US8389500B2Fused heterocyclic compounds as ion channel modulatorsABELMAN MATTHEW·Filed 2009·Granted Mar 5, 2013·16 cites·24 claims
- 1588US11976072B2Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2022·Granted May 7, 2024·1 cites·19 claims
- 1687US10874640B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2019·Granted Dec 29, 2020·2 cites·5 claims
- 1787US2025154116A1Mcl-1 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1884US9403782B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Aug 2, 2016·4 cites·10 claims
- 1983US9255089B2Benzimidazolone derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Feb 9, 2016·7 cites·19 claims
- 2083US8703759B2Fused heterocyclic compounds as ion channel modulatorsKOBAYASHI TETSUYA·Filed 2011·Granted Apr 22, 2014·7 cites·25 claims
- 2183US8158810B2ALDH-2 inhibitors in the treatment of addictionZABLOCKI JEFF·Filed 2009·Granted Apr 17, 2012·7 cites·11 claims
- 2282US12162844B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Dec 10, 2024·0 cites·14 claims
- 2382US9655944B2Inhibitors of hepatitis C virusGILEAD SCIENCES INC·Filed 2016·Granted May 23, 2017·2 cites·2 claims
- 2482US9079901B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2014·Granted Jul 14, 2015·5 cites·24 claims
- 2581US9115096B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Aug 25, 2015·5 cites·13 claims
- 2681US2025197421A1Mcl1 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2780US12161625B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Dec 10, 2024·0 cites·23 claims
- 2880US10335409B2Inhibitors of hepatitis C virusGILEAD PHARMASSET LLC·Filed 2018·Granted Jul 2, 2019·1 cites·2 claims
- 2980US2025361236A9Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3077US12202842B2MCL1 inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Jan 21, 2025·0 cites·8 claims
- 3173US10603318B2Inhibitors of hepatitis C virusGILEAD PHARMASSET LLC·Filed 2019·Granted Mar 31, 2020·0 cites·2 claims
- 3273US2024199596A1Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3373US2023148157A1Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2022·Application pending·0 cites
- 3472US5955481APyridine type thiazolidinesNISSAN CHEMICAL IND LTD·Filed 1998·Granted Sep 21, 1999·19 cites·19 claims
- 3570US2021251957A1Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
- 3668US11932634B2Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2022·Granted Mar 19, 2024·0 cites·20 claims
- 3761US2017290827A1Inhibitors of hepatitis c virusGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 3859US11926628B2Diacylglyercol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2022·Granted Mar 12, 2024·0 cites·20 claims
- 3958US2016130300A1Inhibitors of hepatitis c virusGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 4055US2018282316A1Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 4153US2018042905A1Methods of treating hepatitis b virusGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 4252US10017501B2Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Jul 10, 2018·0 cites·15 claims
- 4351US9682998B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 20, 2017·0 cites·12 claims
- 4450US7776868B2Substituted bicyclic and tricyclic thieno[2,3-d]pyrimidines as A2A adenosine receptor antagonistsGILEAD PALO ALTO INC·Filed 2007·Granted Aug 17, 2010·0 cites·13 claims
- 4549US2016303095A1Methods of treating hepatitis b virusGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 4647US2007208040A1A2a adenosine receptor antagonistsELZEIN ELFATIH·Filed 2007·Application pending·0 cites
- 4746US2020205449A1Hardening inhibitor for brine-containing noodles or brine-containing wonton wrapperYUKI GOSEI YAKUHIN KOGYO KK·Filed 2018·Application pending·0 cites
- 4846US2008207610A1Aldh-2 inhibitors in the treatment of addictionZABLOCKI JEFF·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tetsuya Kobayashi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →